Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 559


Determination of Oocyte-Manipulation, Zygote-Manipulation, and Genome-Reprogramming Effects on the Transcriptomes of Bovine Blastocysts.

Min B, Park JS, Kang YK.

Front Genet. 2018 Apr 24;9:143. doi: 10.3389/fgene.2018.00143. eCollection 2018.


Age-associated bimodal transcriptional drift reduces intergenic disparities in transcription.

Min B, Park M, Jeon K, Park JS, Seo H, Jeong S, Kang YK.

Aging (Albany NY). 2018 Apr 27;10(4):789-807. doi: 10.18632/aging.101428.


Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study.

Choi E, Kim W, Joo SK, Park S, Park JH, Kang YK, Jin SY, Chang MS.

Diagn Pathol. 2018 Apr 3;13(1):23. doi: 10.1186/s13000-018-0698-8.


Origin of Satellite Ganglion Cysts with Effusion in the Flexor Hallucis Longus Tendon Sheath around the Hallux.

Lee JW, Joo MW, Sung JK, Ahn JH, Kang YK.

Clin Orthop Surg. 2018 Mar;10(1):94-98. doi: 10.4055/cios.2018.10.1.94. Epub 2018 Feb 27.


Short-Term and Mid-Term Clinical Outcomes Following Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass: A Meta-Analysis.

Dong L, Kang YK, An XG.

Arq Bras Cardiol. 2018 Mar 19:0. doi: 10.5935/abc.20180044. [Epub ahead of print] English, Portuguese.


A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.

Berlin J, Ramanathan RK, Strickler JH, Subramaniam DS, Marshall J, Kang YK, Hetman R, Dudley MW, Zeng J, Nickner C, Xiong H, Komarnitsky P, Shepherd SP, Hurwitz H, Lenz HJ.

Br J Cancer. 2018 Apr;118(7):938-946. doi: 10.1038/s41416-018-0003-3. Epub 2018 Mar 12.


Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study.

Kang YK, Lee BY, Bucci LR, Stohs SJ.

Nutrients. 2018 Feb 17;10(2). pii: E233. doi: 10.3390/nu10020233.


Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus IV paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy.

Kang YK, Ryu MH, Park SH, Kim JG, Kim JW, Cho SH, Park YL, Park SR, Rha SY, Kang MJ, Cho JY, Kang SY, Roh SY, Ryoo BY, Nam BH, Jo YW, Yoon KE, Oh SC.

Ann Oncol. 2018 Feb 9. doi: 10.1093/annonc/mdy055. [Epub ahead of print]


Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).

Jung M, Ryu MH, Oh DY, Kang M, Zang DY, Hwang IG, Lee KW, Kim KH, Shim BY, Song EK, Sym SJ, Han HS, Park YL, Kim JS, Lee HW, Lee MH, Koo DH, Song HS, Lee N, Yang SH, Choi DR, Hong YS, Lee KE, Maeng CH, Baek JH, Kim S, Kim YH, Rha SY, Cho JY, Kang YK.

Gastric Cancer. 2018 Feb 9. doi: 10.1007/s10120-018-0806-1. [Epub ahead of print]


[Comparison of Diagnosis Values of CD64 Infection Index, CRP, PCT and NEU% in the Leukemia Complicated with Bacterial Infection].

Guo XY, Kang YK, Guo SX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Feb;26(1):132-135. doi: 10.7534/j.issn.1009-2137.2018.01.022. Chinese.


Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.

Kim HS, Ryu MH, Zang DY, Park SR, Han B, Kang WK, Rha SY, Jung M, Kim JS, Kang BW, Lee KH, Rho SY, Kim JH, Kim KC, Cho JW, Choi DR, Lim H, Kang HS, Soh JS, Kim MJ, Seo J, Kang YK.

Gastric Cancer. 2018 Jan 25. doi: 10.1007/s10120-018-0794-1. [Epub ahead of print]


Angiomyolipoma of the Liver without a Fat Component, Mimicking a Hepatocellular Carcinoma.

Woo YM, Ryu SH, Min JW, Kim MR, Park TY, Moon JS, Kang YK.

Korean J Gastroenterol. 2018 Jan 25;71(1):49-53. doi: 10.4166/kjg.2018.71.1.49.


Ultrasound-Guided Intraoperative Radiofrequency Ablation and Surgical Resection for Liver Metastasis from Malignant Gastrointestinal Stromal Tumors.

Yoon IS, Shin JH, Han K, Kim PN, Kim KH, Kang YK, Ko HK.

Korean J Radiol. 2018 Jan-Feb;19(1):54-62. doi: 10.3348/kjr.2018.19.1.54. Epub 2018 Jan 2.


Quantitative Single-Photon Emission Computed Tomography/Computed Tomography for Glomerular Filtration Rate Measurement.

Kang YK, Park S, Suh MS, Byun SS, Chae DW, Lee WW.

Nucl Med Mol Imaging. 2017 Dec;51(4):338-346. doi: 10.1007/s13139-017-0491-8. Epub 2017 Aug 24.


Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.

Na YS, Ryu MH, Yoo C, Lee JK, Park JM, Lee CW, Lee SY, Shin YK, Ku JL, Ahn SM, Kang YK.

Oncotarget. 2017 Sep 11;8(44):76712-76721. doi: 10.18632/oncotarget.20816. eCollection 2017 Sep 29.


A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer.

Sakai D, Chung HC, Oh DY, Park SH, Kadowaki S, Kim YH, Tsuji A, Komatsu Y, Kang YK, Uenaka K, Wijayawardana SR, Wacheck V, Wang X, Yamamura A, Doi T.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1197-1207. doi: 10.1007/s00280-017-3445-z. Epub 2017 Oct 25.


Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.

Sawaki A, Yamada Y, Yamaguchi K, Nishina T, Doi T, Satoh T, Chin K, Boku N, Omuro Y, Komatsu Y, Hamamoto Y, Koizumi W, Saji S, Shah MA, Van Cutsem E, Kang YK, Iwasaki J, Kuriki H, Ohtsuka W, Ohtsu A.

Gastric Cancer. 2018 May;21(3):429-438. doi: 10.1007/s10120-017-0773-y. Epub 2017 Oct 20.


Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Chen LT.

Lancet. 2017 Dec 2;390(10111):2461-2471. doi: 10.1016/S0140-6736(17)31827-5. Epub 2017 Oct 6.


C9/12 Ribbon-Like Structures in Hybrid Peptides Alternating α- and Thiazole-Based γ-Amino Acids.

Bonnel C, Legrand B, Simon M, Martinez J, Bantignies JL, Kang YK, Wenger E, Hoh F, Masurier N, Maillard LT.

Chemistry. 2017 Dec 11;23(69):17584-17591. doi: 10.1002/chem.201704001. Epub 2017 Nov 15.


Supplemental Content

Loading ...
Support Center